Orangutan's chemotherapy treatment for cancer ends

Nov 13, 2012

(AP)—The medical team for an 8-year-old orangutan with cancer in Miami says she no longer needs to undergo chemotherapy.

Peanut, one of the star attractions at Jungle Island, had been undergoing chemotherapy since August after being diagnosed with non-Hodgkin lymphoma.

Her doctors said Tuesday that they decided to stop treatments after three courses of combination -immunotherapy. The team says it's confident Peanut received "an adequate course of therapy" because the disease was detected early on.

Her doctors say imaging is not available to show how effective the treatment was in an . But staff veterinarian Dr. Jason Chatfield says that without , Peanut would not have survived.

The team will be closely monitoring Peanut. She and her twin, Pumpkin, will celebrate their birthday on Dec. 2.

Explore further: Male monkey filmed caring for dying mate (w/ Video)

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Orangutan's cancer treatment similar to humans

Sep 17, 2012

(AP)—Peanut is an 8-year-old orangutan and a star attraction at Miami's Jungle Island. These days she's also got a team of cancer doctors huddling around her, watching as the chemo drip flows into her veins.

Treating peanut allergy through a patch

Mar 02, 2011

Can your peanut-allergic child be treated by simply wearing a patch? That’s what researchers at National Jewish Health are investigating. National Jewish Health, along with four other institutions in the Consortium of ...

New peanut allergy treatment works, study shows

Mar 21, 2011

(PhysOrg.com) -- Allergy experts at the University of Cambridge have convincing evidence that a new treatment for peanut allergies is effective, following a three-year trial.

Recommended for you

Male monkey filmed caring for dying mate (w/ Video)

23 hours ago

(Phys.org) —The incident was captured by Dr Bruna Bezerra and colleagues in the Atlantic Forest in the Northeast of Brazil.  Dr Bezerra is a Research Associate at the University of Bristol and a Professor ...

Orchid named after UC Riverside researcher

Apr 17, 2014

One day about eight years ago, Katia Silvera, a postdoctoral scholar at the University of California, Riverside, and her father were on a field trip in a mountainous area in central Panama when they stumbled ...

In sex-reversed cave insects, females have the penises

Apr 17, 2014

Researchers reporting in the Cell Press journal Current Biology on April 17 have discovered little-known cave insects with rather novel sex lives. The Brazilian insects, which represent four distinct but re ...

Fear of the cuckoo mafia

Apr 17, 2014

If a restaurant owner fails to pay the protection money demanded of him, he can expect his premises to be trashed. Warnings like these are seldom required, however, as fear of the consequences is enough to ...

User comments : 0

More news stories

Researchers successfully clone adult human stem cells

(Phys.org) —An international team of researchers, led by Robert Lanza, of Advanced Cell Technology, has announced that they have performed the first successful cloning of adult human skin cells into stem ...

Male monkey filmed caring for dying mate (w/ Video)

(Phys.org) —The incident was captured by Dr Bruna Bezerra and colleagues in the Atlantic Forest in the Northeast of Brazil.  Dr Bezerra is a Research Associate at the University of Bristol and a Professor ...

Researchers develop new model of cellular movement

(Phys.org) —Cell movement plays an important role in a host of biological functions from embryonic development to repairing wounded tissue. It also enables cancer cells to break free from their sites of ...

Health care site flagged in Heartbleed review

People with accounts on the enrollment website for President Barack Obama's signature health care law are being told to change their passwords following an administration-wide review of the government's vulnerability to the ...

Airbnb rental site raises $450 mn

Online lodging listings website Airbnb inked a $450 million funding deal with investors led by TPG, a source close to the matter said Friday.